[Influence of Pendiomide and Largactil on the peripheral blood vessels in scleroderma].
D000328:Adult; D001341:Autonomic Nervous System / Q000503:physiopathology; D008725:Bis-Trimethylammonium Compounds / Q000008:administration & dosage*; D001808:Blood Vessels / Q000187:drug effects* / Q000503:physiopathology; D002746:Chlorpromazine / Q000008:administration & dosage*; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010991:Plethysmography; D011928:Raynaud Disease / Q000188:drug therapy* / Q000503:physiopathology; D012595:Scleroderma, Systemic / Q000188:drug therapy* / Q000503:physiopathology
D008725:Bis-Trimethylammonium Compounds; D004304:Dosage Forms; D002746:Chlorpromazine
Med Klin. 1963 Sep 13;58:1511-3
14050308
Hautarzt. 1965 Mar;16:109-13
14304819
Arch Klin Exp Dermatol. 1968;233(2):146-55
5721212
Pol Przegl Chir. 1956 Jul;28(7):695-8
13388759
Acta Neuroveg (Wien). 1958;19(1-2):53-67
13605684
Hautarzt. 1952 Jul;3(7):301-4
12980477
Z Haut Geschlechtskr. 1966 Apr 1;40(7):237-44
4228542
Arch Klin Exp Dermatol. 1957;206:209-16
13522044
Der Einfluss von Pendiomid und Largactil auf die peripheren Gefässe bei Sklerodermie.